Methods used in identifying glioblastoma
US8673572B2 · kind B2 · utility
2Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 25, 2010 |
| Grant date | Mar 18, 2014 |
| Priority date | — |
| Expiry date | Sep 12, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.